In contrast to breast and prostate cancer, FAK has been shown to present the most important determinant downstream of β1 integrin for radiochemoresistance in HNSCC and its phosphorylation status is directly linked to the activation of β1 integrin [39,42,46]. Here, PTK2 is linked to head and neck squamous cell carcinoma.